Among the six IAP antagonists, XIAP-specific antagonists A4 and B3 showed highest potency against neuroblastoma cells across the panel of cell lines with the lowest IC50 achieved (2–15 μmol/L; Supplementary Table S2; Fig. 2A). Here, XIAP is linked to neuroblastoma.